Crossmark

Clinical overview of metronomic chemotherapy in breast cancer

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2015.131

Published Online: 2015-08-04

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Munzone, Elisabetta

Colleoni, Marco
License Information

Text and Data Mining valid from 2015-08-04
More Information

Article History

First Online: 4 August 2015

Competing interests

: M.C. declares he receives honoraria for consultancy for AbbVie, AstraZeneca, Novartis, Pierre Fabre and Taiho Pharmaceuticals. E.M. declares no competing interests.